Once-daily raltegravir works as well as twice-daily for initial HIV treatment
Bone loss partially recovers after stopping PrEP, twice-yearly kidney monitoring is enough for most
Dolutegravir plus lamivudine dual therapy works well as initial HIV treatment
Access to HIV home tests doubles the frequency of HIV testing in Australian gay men
'Test and treat': large study fails to show an impact on new HIV infections
Earlier HIV treatment is not over-burdening health services
Long-acting injectable drugs work well for HIV maintenance therapy
Viral load pilot study shows roll-out will depend on an educated workforce
World’s largest study of HIV self-testing gets off the ground
